Back
Akero Therapeutics Vs. FirstCash Holdings Industry Stock Comparison
Sell
50
AKRO
Akero Therapeutics
Last Price:
22.13
Seasonality Move:
6.97%
Buy
58
FCFS
FirstCash Holdings
Last Price:
116.64
Seasonality Move:
5.12%
Sell
50
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $22.13. The Score for AKRO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
FirstCash Holdings (FCFS)
is a Buy
Is FirstCash Holdings a Buy, Sell or Hold?
- The current FirstCash Holdings [FCFS] share price is $116.51. The Score for FCFS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- FCFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $22.13
The current trend is relatively stagnant and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
FCFS Stock Price Chart
What is FirstCash Holdings's stock price today?
-
The FirstCash Holdings share price today is $116.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCFS is experiencing slight selling pressure.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.95 | Sell |
| Relative Strength Index (14 RSI): | 53.45 | Buy |
| Chaikin Money Flow: | 694389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.96 - 22.74) | Buy |
| Bollinger Bands (100): | (20.25 - 26.05) | Sell |
FCFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.43 | Sell |
| Relative Strength Index (14 RSI): | 39.27 | Sell |
| Chaikin Money Flow: | -60658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.48 - 131.08) | Sell |
| Bollinger Bands (100): | (110.61 - 124.15) | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.97 | Buy |
| 20-day SMA: | 20.9 | Buy |
| 50-day SMA: | 24.25 | Sell |
| 200-day SMA: | 28.08 | Sell |
| 8-day EMA: | 20.44 | Buy |
| 20-day EMA: | 21.1 | Buy |
| 50-day EMA: | 22.47 | Sell |
| 200-day EMA: | 27.02 | Sell |
FCFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.13 | Buy |
| 20-day SMA: | 124.24 | Sell |
| 50-day SMA: | 121.6 | Sell |
| 200-day SMA: | 109.19 | Buy |
| 8-day EMA: | 117.49 | Sell |
| 20-day EMA: | 121.04 | Sell |
| 50-day EMA: | 121.12 | Sell |
| 200-day EMA: | 111.4 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
FirstCash Holdings Earnings Growth & FCFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.05 per share, and an increase next year of $1.23 per share.
Akero Therapeutics Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
FirstCash Holdings Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||